Rhodia does fit nicely the criteria Solvay identified, including improving its presence in emerging economies, lowering its energy and environmental footprint, and" />
IHS Chemical Week

Chemical Week Magazine :: Viewpoint

Solvay Reinvests

10:47 AM MDT | April 15, 2011

Solvay has lined up its desired chemical reinvestment, using proceeds from the February 2010 sale of its pharma business, with a €3.4 billion ($4.9 billion) cash offer for Rhodia ( p. 8). Rhodia had not turned up much in Solvay deal speculation, which has included just about every European chemical maker in Europe with a market cap below €10 billion. Rhodia does fit nicely the criteria Solvay identified, including improving its presence in emerging economies, lowering its energy and environmental footprint, and...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa